Screener
Exelixis EXEL Japan — Total revenues
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Exelixis in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Exelixis’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:13 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q3 2026
- Accession
- 0000939767-26-000098
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| U.S. | $578,361 | $524,768 | $1,136,907 | $1,041,952 |
| Europe | 46,007 | 37,033 | 85,575 | 69,739 |
| Japan | 4,322 | 6,460 | 17,020 | 12,017 |
| Total revenues | $628,690 | $568,261 | $1,239,502 | $1,123,708 |
Item 1. Financial Statements.
FAQ
- What is Exelixis's japan — total revenues?
- Exelixis (EXEL) reported japan — total revenues of $4.32M in Q2 2026.
- How has Exelixis's japan — total revenues changed year-over-year?
- Exelixis's japan — total revenues decreased by 33.1% year-over-year, from $6.46M to $4.32M.
- What is the long-term trend for Exelixis's japan — total revenues?
- Over 4 years (2021 to 2025), Exelixis's japan — total revenues has grown at a -12.4% compound annual growth rate (CAGR), from $43.5M to $25.59M.
- What does japan — total revenues mean?
- This metric represents the total gross revenue generated from the sale of pharmaceutical products and licensing arrangements within the Japanese geographic market. It captures the financial performance of the company's oncology portfolio in this specific region, reflecting market penetration and commercial success of approved treatments. This figure is critical for assessing the company's international footprint and the effectiveness of its regional commercialization strategy.
Ask your AI about Exelixis's japan — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude